• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Erick Gamelin, Michèle Boisdron-Celle, +6 authors Jean Robert
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1999 (First Publication: 1 April 1999)
  • PURPOSE Patients with genetic fluorouracil (5-FU) catabolic deficiencies are at high risk for severe toxicity. To predict 5-FU catabolic deficiencies and toxic side effects, we conducted aExpand
  • Erick Gamelin, Michèle Boisdron-Celle, +19 authors Jean Robert
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1998 (First Publication: 1 April 1998)
  • PURPOSE A relationship between fluorouracil (5-FU) dose and response has been previously shown in advanced colorectal cancer. In a previous study with 5-FU stepwise dose escalation in a weeklyExpand
  • Marie-Christine Etienne-Grimaldi, Patricia Formento, +11 authors Gérard A. Milano
  • Medicine
  • British journal of clinical pharmacology
  • 2011 (First Publication: 1 June 2011)
  • WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Functional polymorphisms on the VEGF-A gene, known to be linked to cancer risk or to VEGF-A plasma concentrations, have been identified. So far, limitedExpand
  • Olivier Trédan, J.-F. Geay, +8 authors Gilles Freyer
  • Medicine
  • Annals of oncology : official journal of the…
  • 2007 (First Publication: 20 November 2006)
  • BACKGROUND To determine the feasibility of two chemotherapy regimens in elderly patients with advanced ovarian carcinoma (AOC). PATIENTS AND METHODS Eighty-three patients >or=70 years wereExpand
  • Erick Gamelin, Anne Le Bouil, +9 authors Patrick Allain
  • Medicine
  • Clinical cancer research : an official journal of…
  • 1997 (First Publication: 1 June 1997)
  • The cumulative pharmacokinetic pattern of oxaliplatin, a new diamminecyclohexane platinum derivative, was studied in patients with metastatic colorectal cancer. Oxaliplatin was administered by i. v.Expand
  • Sophie Catherine Abrial, Frédérique Penault-Llorca, +8 authors Philippe Chollet
  • Medicine
  • Breast Cancer Research and Treatment
  • 2005 (First Publication: 22 November 2005)
  • SummaryPrognostic factors are used to help clinical decision-making in selecting the appropriate treatment for individual patients. The purpose of this retrospective study was to identify one or moreExpand
  • Patrice Viens, Thao Palangié, +17 authors Pierre Pouillart
  • Medicine
  • British Journal of Cancer
  • 1999 (First Publication: 1 October 1999)
  • SummaryDespite the generalization of induction chemotherapy and a better outcome for chemosensitive diseases, the prognosis of inflammatory breast cancer (IBC) is still poor. In this work, weExpand
  • Sophie Catherine Abrial, Frédérique Penault-Llorca, +8 authors Philippe Chollet
  • Medicine
  • Breast Cancer Research and Treatment
  • 2005
  • Prognostic factors are used to help clinical decision-making in selecting the appropriate treatment for individual patients. The purpose of this retrospective study was to identify one or moreExpand
  • C. Abrial, I. van Praagh, +7 authors P. Chollet
  • Medicine
  • The oncologist
  • 2005 (First Publication: 1 April 2005)
  • This phase II study investigated the efficacy and tolerability of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel (VEP protocol) in women with stage II/III operableExpand
  • Karim S Fizazi, Marie-Stéphanie Aubelle, +6 authors Agnès Laplanche
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2009
  • 5031 Background: Cisplatin plus etoposide-based chemotherapy is the recommended treatment and results in a high cure rate in patients (pts) with metastatic seminoma (Eur Urol 2008, 53: 478-96).Expand